Dr. Jackson is a physician scientist specializing in the field of Neonatal-Perinatal Medicine.
Education and Training
BA, Southern Methodist University
MD, University of Texas Southwestern Medical Center
Residency in Pediatrics, University of Alabama at Birmingham
Fellowship in Neonatal-Perinatal Medicine, The University of North Carolina at Chapel Hill
MPH, The University of North Carolina at Chapel Hill
Research
Dr. Jackson’s research interests include clinical trials operations, clinical pharmacology, and epigenetic analyses. His goal is to combine these interests to improve the outcomes of infants through drug development for diseases with limited therapies, including bronchopulmonary dysplasia and hypoxic-ischemic encephalopathy. His work on dose optimization for novel neuroprotective drugs to treat hypoxic-ischemic encephalopathy is funded through a K23 award from the NIH.
